Testing effectiveness (Phase 2)Study completedNCT01397227
What this trial is testing
Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model
Who this might be right for
Malaria
Crucell Holland BV 36